53 related articles for article (PubMed ID: 1799314)
1. [Secondary immunodeficiency in Pseudotuberculosis in man and in experiment].
Isachkova LM; Zhavoronkov AA
Arkh Patol; 1991; 53(11):28-33. PubMed ID: 1799314
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological study of Yersinia enterocolitica and Yersinia pseudotuberculosis infections in Shimane Prefecture, Japan.
Fukushima H; Tsubokura M; Otsuki K; Kawaoka Y; Nishio R; Moriki S; Nishino Y; Mototsune H; Karino K
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 May; 180(5-6):515-27. PubMed ID: 3895776
[TBL] [Abstract][Full Text] [Related]
3. [Interaction of Yersinia pseudotuberculosis with the epithelium of the small intestine in experimental infection].
Isachkova LM; Zhavoronkov AA; Timchenko NF
Biull Eksp Biol Med; 1985 Jul; 100(7):117-20. PubMed ID: 3893561
[TBL] [Abstract][Full Text] [Related]
4. [The basic features of the pathogenesis of pseudotuberculosis (yersiniosis)].
Avtsyn AP; Isachkova LM; Zhavoronkov AA; Somov GP; Makhnev MV
Arkh Patol; 1990; 52(5):3-7. PubMed ID: 2204325
[TBL] [Abstract][Full Text] [Related]
5. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. IV. Specificity of antigens].
Rastawicki W
Med Dosw Mikrobiol; 2008; 60(1):27-37. PubMed ID: 18634341
[TBL] [Abstract][Full Text] [Related]
6. Trypsin-like proteinase and its endogenous inhibitor from Yersinia pseudotuberculosis. Biological activity.
Burtseva TI; Loenko YN
Biochemistry (Mosc); 1999 Sep; 64(9):986-9. PubMed ID: 10521713
[TBL] [Abstract][Full Text] [Related]
7. Some aspects of the immunology of pseudotuberculosis.
Besednova NN; Somov GP
J Hyg Epidemiol Microbiol Immunol; 1982; 26(3):235-41. PubMed ID: 6754810
[TBL] [Abstract][Full Text] [Related]
8. Influence of Yersinia pseudotuberculosis outer proteins (Yops) on interleukin-12, tumor necrosis factor alpha and nitric oxide production by peritoneal macrophages.
Monnazzi LG; Carlos IZ; de Medeiros BM
Immunol Lett; 2004 Jun; 94(1-2):91-8. PubMed ID: 15234540
[TBL] [Abstract][Full Text] [Related]
9. [Pathomorphology of the intestine and regional lymphatic system in pseudotuberculosis].
Isachkoa LM; Zhavoronkov AA; Antonenko FF; Timchenko NF
Arkh Patol; 1988; 50(9):22-8. PubMed ID: 3202697
[TBL] [Abstract][Full Text] [Related]
10. Attenuation and preserved immunogenic potential of Yersinia pseudotuberculosis mutant strains evidenced in oral pig model.
Najdenski H; Golkocheva-Markova E; Kussovski V; Vesselinova A; Garbom S; Wolf-Watz H
Zoonoses Public Health; 2009 May; 56(4):157-68. PubMed ID: 18793276
[TBL] [Abstract][Full Text] [Related]
11. Turning Yersinia pathogenesis outside in: subversion of macrophage function by intracellular yersiniae.
Pujol C; Bliska JB
Clin Immunol; 2005 Mar; 114(3):216-26. PubMed ID: 15721832
[TBL] [Abstract][Full Text] [Related]
12. Th1-type immune response to infection by pYV-cured phoP-phoQ null mutant of Yersinia pseudotuberculosis is defective in mouse model.
Kumar S; Balakrishna K; Agarwal GS; Merwyn S; Rai GP; Batra HV; Sardesai AA; Gowrishankar J
Antonie Van Leeuwenhoek; 2009 Jan; 95(1):91-100. PubMed ID: 18985430
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of the plasmid composition of Yersinia pseudotuberculosis strains and its use for typing pseudotuberculosis pathogens].
Shubin FN; Gintsburg AL; Kitaev VM; Ianishevskiĭ NV; Zenkova ZG
Mol Gen Mikrobiol Virusol; 1989 Jun; (6):20-5. PubMed ID: 2682219
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of 2 methods of hemagglutination tests for antibodies against strains of Yersinia enterocolitica and Yersinia pseudotuberculosis].
Rutová J
Cesk Epidemiol Mikrobiol Imunol; 1989 Jan; 38(1):40-7. PubMed ID: 2646030
[TBL] [Abstract][Full Text] [Related]
15. [Pseudotuberculosis from the clinical point of view (synonyms: Yersinia pseudotuberculosis infection, Pasteurella pseudotuberculosis infection, lymphadenitis mesenterialis Masshoff)].
Bretschneider R; Kirmse H
Z Arztl Fortbild (Jena); 1974 Jun; 68(12):592-8. PubMed ID: 4611060
[No Abstract] [Full Text] [Related]
16. [Method for producing monoreceptor pseudotuberculosis sera].
Tseneva GIa; Messorosh VG
Lab Delo; 1983; (10):54-5. PubMed ID: 6196538
[No Abstract] [Full Text] [Related]
17. LcrV synthesis is altered by DNA adenine methylase overproduction in Yersinia pseudotuberculosis and is required to confer immunity in vaccinated hosts.
Badie G; Heithoff DM; Mahan MJ
Infect Immun; 2004 Nov; 72(11):6707-10. PubMed ID: 15501808
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenesis and pathologic anatomy of human Yersinia infections].
Kühn H; Freissler G
Leber Magen Darm; 1983 Nov; 13(6):270-7. PubMed ID: 6392801
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility to Yersinia pseudotuberculosis infection is linked to the pattern of macrophage activation.
Tansini A; de Medeiros BM
Scand J Immunol; 2009 Apr; 69(4):310-8. PubMed ID: 19284495
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Kawasaki disease showing elevated antibody titres of Yersinia pseudotuberculosis.
Tahara M; Baba K; Waki K; Arakaki Y
Acta Paediatr; 2006 Dec; 95(12):1661-4. PubMed ID: 17129979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
